Fidelity Investments
ABEO icon

Fidelity Investments’s Abeona Therapeutics ABEO Stock Holding History

Fidelity Investments’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$873K Buy
194,813
+26,358
+16% +$132K ﹤0.01% 2924
2025
Q4 		$888K Buy
168,455
+162,671
+2,812% +$819K ﹤0.01% 2895
2025
Q3 		$30.5K Sell
5,784
-1,296
-18% -$8.22K ﹤0.01% 4181
2025
Q2 		$40.2K Buy
+7,080
New +$40.3K ﹤0.01% 3995
2024
Q2 		– Sell
-40
Closed -$290 – 5347
2024
Q1 		$290 Buy
+40
New +$253 ﹤0.01% 4891
2023
Q3 		– Sell
-16
Closed -$64 – 5266
2023
Q2 		$64 Buy
+16
New +$56 ﹤0.01% 4996
2019
Q4 		– Sell
-29,367
Closed -$1.66M – 3737
2019
Q3 		$1.66M Sell
29,367
-140,077
-83% -$10.5M ﹤0.01% 2311
2019
Q2 		$20.2M Sell
169,444
-118,171
-41% -$19.8M ﹤0.01% 1618
2019
Q1 		$52.9M Sell
287,615
-52
-0% -$9.3K 0.01% 1191
2018
Q4 		$51.3M Buy
287,667
+7
+0% +$1.53K 0.01% 1123
2018
Q3 		$92.1M Buy
287,660
+3,888
+1% +$1.38M 0.01% 988
2018
Q2 		$114M Buy
283,772
+91,640
+48% +$40M 0.01% 893
2018
Q1 		$68.9M Buy
192,132
+35,988
+23% +$13.4M 0.01% 1150
2017
Q4 		$61.9M Buy
+156,144
New +$64.6M 0.01% 1196

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments's ABEO Position: Q1 2026 in Review

Fidelity Investments increased its Abeona Therapeutics (ABEO) stake by 16% in Q1 2026, buying an estimated $132K and bringing the position to 194,813 shares worth $873K. The position accounts for ﹤0.01% of the portfolio, ranked #2924.

Fidelity Investments first reported a position in ABEO in Q4 2017 and has held it in 14 quarters since. The position peaked at $114M in Q2 2018. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Fidelity Investments held 194,813 shares of Abeona Therapeutics worth $873K as of Q1 2026.
  • Fidelity Investments bought 26,358 Abeona Therapeutics shares in Q1 2026, an estimated $132K.
  • Abeona Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2924 holding.
  • Fidelity Investments first reported a position in Abeona Therapeutics in Q4 2017 and has held it in 14 quarters since.
  • Fidelity Investments's Abeona Therapeutics position peaked at $114M in Q2 2018.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.